Homosalate vs Advantame: which is worse?
Quick answer: Both score equally on our risk model. Homosalate is restricted in the EU and allowed in the US; Advantame is — in the EU and — in the US.
| Property | Homosalate | Advantame |
|---|---|---|
| EU status | Restricted | — |
| US status | Allowed | — |
| Risk level | medium | — |
| Banned in | — | — |
| Restricted in | European Union | European Union (ADI 5 mg/kg body weight) |
| Category | uv filter | additive |
| Where it hides | sunscreen, SPF moisturizer, SPF foundation | — |
What is Homosalate?
Homosalate is an organic UV filter that absorbs UVB radiation.
What is Advantame?
Advantame is the newest FDA-approved synthetic sweetener, approved in 2014. Like neotame, it is a structural derivative of aspartame but with a vanillin-derived substituent. It is approximately 20,000 times sweeter than sucrose — the most potent sweetener currently approved for food use in the US.
Documented risks
Homosalate: A suspected endocrine disruptor; the EU limits it to 7.34% in face products (2025), well below typical US concentrations.
Advantame: Advantame is the newest approved high-intensity sweetener with the least post-approval safety data. The FDA approval was based on extensive pre-market animal studies showing no significant toxicity, carcinogenicity, reproductive toxicity, or neurotoxicity at relevant doses. EFSA approved it for EU use in 2014, finding no safety concerns based on the submitted data. Like other synthetic sweeteners, advantame has not been studied for long-term effects in large human populations post-approval. The same gut microbiome and glucose tolerance concerns raised for other sweeteners (aspartame, sucralose, acesulfame K) have not been specifically studied for advantame, though the class-wide concerns are relevant. Given its 2014 approval date, independent long-term safety studies are still limited.
Scan a barcode and we'll flag both Homosalate and Advantame (plus 200+ other ingredients banned overseas).
Scan free →